Publikationen von Manoj Mannil

Fledrich, R.; Mannil, M.; Leha, A.; Ehbrecht, C.; Solari, A.; Pelayo-Negro, A. L.; Berciano, J.; Schlotter-Weigel, B.; Schnizer, T. J.; Prukop, T. et al.; Garcia-Angarita, N.; Czesnik, D.; Haberlová, J.; Mazanec, R.; Paulus, W.; Beissbarth, T.; Walter, M. C.; CMT-TRIAAL; Hogrel, J.-Y.; Dubourg, O.; Schenone, A.; Baets, J.; De Jonghe, P.; Shy, M. E.; Horvath, R.; Pareyson, D.; Seeman, P.; Young, P.; Sereda, M. W.: Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A. Journal of Neurology, Neurosurgery & Psychiatry 88 (11), S. 941 - 952 (2017)

Mannil, M.; Solari, A.; Leha, A.; Pelayo-Negro, A. L.; Berciano, J.; Schlotter-Weigel, B.; Walter, M. C.; Rautenstrauss, B.; Schnizer, T. J.; Schenone, A. et al.; Seeman, P.; Kadian, C.; Schreiber, O.; Angarita, N. G.; Fabrizi, G. M.; Gemignani, F.; Padua, L.; Santoro, L.; Quattrone, A.; Vita, G.; Calabrese, D.; CMT-TRIAAL/CMT-TRAUK Group; Young, P.; Laurà, M.; Haberlová, J.; Mazanec, R.; Paulus, W.; Beissbarth, T.; Shy, M. E.; Reilly, M. M.; Pareyson, D.; Sereda, M. W.: Selected items from the Charcot-Marie-Tooth (CMT) neuropathy score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. Neuromuscular Disorders 24 (11), S. 1003 - 1017 (2014)